693230-06-7 Usage
Type of compound
Guanidine derivative
Pharmaceutical research
Potential drug candidate
Biological activities
Wide range
Potential as an antipsychotic
Yes
Potential as an anxiolytic agent
Yes
Modulation of neurotransmitter systems
Yes
Preclinical studies
Shown promise for treatment of certain types of cancer and inflammatory diseases
Ongoing research
Exploring potential applications in various therapeutic areas
Check Digit Verification of cas no
The CAS Registry Mumber 693230-06-7 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 6,9,3,2,3 and 0 respectively; the second part has 2 digits, 0 and 6 respectively.
Calculate Digit Verification of CAS Registry Number 693230-06:
(8*6)+(7*9)+(6*3)+(5*2)+(4*3)+(3*0)+(2*0)+(1*6)=157
157 % 10 = 7
So 693230-06-7 is a valid CAS Registry Number.
693230-06-7Relevant academic research and scientific papers
Synthesis, structure-activity relationship and biological evaluation of 2,4,5-trisubstituted pyrimidine CDK inhibitors as potential anti-tumour agents
Shao, Hao,Shi, Shenhua,Foley, David W.,Lam, Frankie,Abbas, Abdullah Y.,Liu, Xiangrui,Huang, Shiliang,Jiang, Xiangrui,Baharin, Nadiah,Fischer, Peter M.,Wang, Shudong
, p. 447 - 455 (2013/11/19)
A series of 2,4,5-trisubstituted pyrimidines have been synthesised and characterised, which exhibited potent CDK inhibition and anti-proliferative activities. The structure-activity relationship is analysed and a rational for CDK9 selectivity is discussed
